A Study to Evaluate the Safety and Pharmacokinetics of Ciprofloxacin in Adults and Children Aged 6 - 12 Years With Cystic Fibrosis Following Inhalation of Ciprofloxacin Dry Powder.

Trial Profile

A Study to Evaluate the Safety and Pharmacokinetics of Ciprofloxacin in Adults and Children Aged 6 - 12 Years With Cystic Fibrosis Following Inhalation of Ciprofloxacin Dry Powder.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Nov 2013

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Pseudomonal infections
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Dec 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
    • 02 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Oct 2010 Planned end date changed from 1 Sep 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top